How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Blood Dialysis Water Treatment Equipment Market
- By Product Type: Reverse Osmosis Systems, Ultrafiltration Systems, Deionization Systems, Water Softeners, Pre-treatment Systems
- By End User: Hospitals, Dialysis Centers, Clinics, Home Healthcare Settings, Research Laboratories
- By Technology: Membrane Filtration, Ion Exchange, Electrodeionization, Ultraviolet Disinfection, Chemical Treatment
- By Application: Hemodialysis, Peritoneal Dialysis, Continuous Renal Replacement Therapy (CRRT)
- By Component: Pretreatment Units, Water Purification Units, Distribution Systems, Storage Tanks, Monitoring and Control Systems
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Reverse Osmosis Systems leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 14 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 298 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.183 →
- 12 Company Profiles 14 players: SWOT & benchmarking p.191 →
Full report · locked preview
Everything inside the Blood Dialysis Water Treatment Equipment Market report
A complete, evidence-based study - 12 chapters and 125 sections covering market size, segmentation across 5 axes, regional analysis and 14 company profiles, forecast to 2033.
Segmentation covered
Product Type 5
End User 5
Technology 5
Application 3
Component 5
Companies profiled
Fresenius Medical Care AG & Co. KGaA
Baxter International Inc.
Nikkiso Co. Ltd.
Nipro Corporation
Asahi Kasei Medical Co. Ltd.
Toray Industries Inc.
Jafron Biomedical Co. Ltd.
Medica S.p.A.
WEGO Group
B. Braun Melsungen AG
Nikkiso Cryo Inc.
DaVita Inc.
+2 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
14 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Fresenius Medical Care AG & Co. KGaA
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Baxter International Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Nikkiso Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Nipro Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Asahi Kasei Medical Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Toray Industries Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Jafron Biomedical Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Medica S.p.A.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →WEGO Group
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →B. Braun Melsungen AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Nikkiso Cryo Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →DaVita Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →Gambro (a subsidiary of Baxter)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Nikkiso Water Systems
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →
Global · 2025–2033
$1,881M by 2033 · 4.6% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Reverse Osmosis Systems49.0
- Ultrafiltration Systems10.7
- Deionization Systems15.9
- Water Softeners12.3
- Pre-treatment Systems12.2
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$432.7M → $556.6M · 3.2%
Europe$301.6M → $467.8M · 5.6%
Asia Pacific$275.4M → $411.6M · 5.2%
Latin America$170.5M → $225.4M · 3.6%
Middle East and Africa$131.1M → $207.9M · 5.9%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →4.572026
4.572027
4.592028
4.602029
4.632030
4.642031
4.642032
4.652033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Fresenius Medical Care AG & Co. KGaA13.1
- Baxter International Inc.21.5
- Nikkiso Co. Ltd.7.8
- Nipro Corporation5.7
- Asahi Kasei Medical Co. Ltd.14.0
- Toray Industries Inc.10.0
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type26.7%
End User21.3%
Technology20.7%
Application15.3%
Component16.1%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America29.8
- Europe25.0
- Asia Pacific22.0
- Latin America12.1
- Middle East and Africa11.1
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 97 | 98 | 88 | 73 | 77 | 80 | 86 |
| Baxter International Inc. | 88 | 80 | 78 | 87 | 93 | 79 | 84 |
| Nikkiso Co. Ltd. | 63 | 74 | 75 | 62 | 74 | 62 | 68 |
| Nipro Corporation | 67 | 57 | 63 | 81 | 75 | 63 | 68 |
| Asahi Kasei Medical Co. Ltd. | 59 | 74 | 68 | 61 | 58 | 63 | 64 |
| Toray Industries Inc. | 53 | 47 | 58 | 47 | 65 | 66 | 56 |
| Jafron Biomedical Co. Ltd. | 60 | 53 | 49 | 44 | 42 | 51 | 50 |
| Medica S.p.A. | 53 | 40 | 35 | 43 | 54 | 48 | 46 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Fresenius Medical Care AG & Co. KGaA
- Baxter International Inc.
- Nikkiso Co. Ltd.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | ✓ | ✓ | ✓ | ◐ | ◐ | ◐ |
| Baxter International Inc. | ✓ | ✓ | ◐ | ✓ | ✓ | ◐ |
| Nikkiso Co. Ltd. | ◐ | ✓ | ✓ | ◐ | ◐ | ◐ |
| Nipro Corporation | ◐ | ◐ | − | ✓ | ✓ | ◐ |
| Asahi Kasei Medical Co. Ltd. | ◐ | − | ◐ | ◐ | − | ◐ |
| Toray Industries Inc. | − | − | − | ◐ | ◐ | ◐ |
| Jafron Biomedical Co. Ltd. | ◐ | − | − | − | − | ◐ |
| Medica S.p.A. | − | − | − | ◐ | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Fresenius Medical Care AG & Co. KGaA86
2Baxter International Inc.84
3Nikkiso Co. Ltd.68
4Nipro Corporation68
5Asahi Kasei Medical Co. Ltd.64
6Toray Industries Inc.56
7Jafron Biomedical Co. Ltd.50
8Medica S.p.A.46
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Fresenius Medical Care AG & Co. KGaABaxter International Inc.
Challenger2
Strong scale, closing on the leaders.
Nikkiso Co. Ltd.Nipro Corporation
Contender1
Focused players with pockets of strength.
Asahi Kasei Medical Co. Ltd.
Niche3
Specialists in a single segment or region.
Toray Industries Inc.Jafron Biomedical Co. Ltd.Medica S.p.A.
Go-to-market strategy
Land Product Type in North America, then scale across Blood Dialysis Water Treatment Equipment Market — a $186M beachhead inside a $2.54B market.
Beachhead (SOM)$186Mobtainable near-term
Serviceable (SAM)$1.06Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion87 fit
Reverse Osmosis Systems
Best fit — highest urgency & budget in Product Type.
Economic buyer79 fit
Ultrafiltration Systems
Strong fit — clear ROI and a fast path to value.
End user66 fit
Deionization Systems
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add End User & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Technology
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel27%
Digital / self-serve22%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Blood Dialysis Water Treatment Equipment Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified40%
Sales qualified24%
Evaluation14%
Closed-won6%
$16.2KCAC
$59KLTV
3.6:1LTV : CAC
< 5 moCAC payback
Investment thesis
Blood Dialysis Water Treatment Equipment Market is a durable-growth opportunity — $8.83B by 2033, compounding at 9.5%.
TAM · 2025$4.27Btoday
TAM · 2033$8.83Bforecast
CAGR9.5%2027–2033
Cumulative$56.8Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$8.83BTotal addressable market
SAM$3.70BServiceable available market
SOM$727MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →9.5% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
14+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$8.83BLarge & growingTAM by 2033 at 9.5% CAGR
$3.70BServiceable nowreachable with today’s model
$727MBeachhead winobtainable near-term share
14+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$6.89BBear6.2% CAGR
$8.83BBase9.5% CAGR
$11.3BBull12.5% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & End User optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Blood Dialysis Water Treatment Equipment Market — a $7.10B market by 2033. Plan: grow share from 7.0% to 15.3%.
Market size · 2033$7.10Btotal addressable
Market CAGR5.3%2027–2033
Target share15.3%from 7.0% today
Revenue ambition$1.09Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.0% | 15.3% | Ahead |
| Revenue | $527M | $1.09B | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Behind |
| Gross margin | 35.8% | 43.7% | On track |
| Customer retention | 89.6% | 92.3% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build End User capability
A defensible second engine — invest in End User to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch End User
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $122M capacity & capability investment
- Greenlight bolt-on M&A in End User
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossBehind
- Input-cost & supply riskAt risk
- Regulatory / policy changeAt risk
- Execution & talentOn track
Sales deck · value proposition
Win the Blood Dialysis Water Treatment Equipment Market conversation — a $2.89B market you can size, segment and defend in minutes.
Market size · 2033$2.89Btotal opportunity
Growth5.8%CAGR to 2033
Addressable buyers1,782+accounts in scope
Typical ROI4.5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.5×return on cost, year one
< 4 mopayback period
$73K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
14+players profiled in this market
Coverage includes
Fresenius Medical Care AG & Co. KGaABaxter International Inc.Nikkiso Co. Ltd.Nipro CorporationAsahi Kasei Medical Co. Ltd.Toray Industries Inc.Jafron Biomedical Co. Ltd.Medica S.p.A.+6 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Blood Dialysis Water Treatment Equipment Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Blood Dialysis Water Treatment Equipment Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Blood Disease Drugs Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportBlood Donation Market
Market size, share, segmentation and regional forecast.
$6.1B market · 2025 base year
View reportBlood Donor Armchairs Market
Market size, share, segmentation and regional forecast.
$1.0B market · 2025 base year
View reportBlood Electric Chair Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportBlood Factors Market
Market size, share, segmentation and regional forecast.
$416M market · 2025 base year
View reportBlood Flow Measurement Devices (Ultrasonic Doppler, Laser Doppler and Electromagnetic Blood Flowmeters) Market
Market size, share, segmentation and regional forecast.
$814M market · 2025 base year
View reportBlood Flow Restriction Bands Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportBlood Gas Analyzer with Touchscreen Market
Market size, share, segmentation and regional forecast.
$698M market · 2025 base year
View reportBlood Gas Analyzer/Blood Gas and Electrolyte Analyzer Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportBlood Gas Electrolyte Analyzer Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportBlood Glucometer Market
Market size, share, segmentation and regional forecast.
$967M market · 2025 base year
View reportBlood Glucose (SMBG) (Test Strips, Lancet, Meter) Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report ships as a formatted PDF, a fully editable XLSX containing all underlying data tables, and a presentation-ready PPT deck - so you can re-chart, re-model, or drop any figure straight into your own deck.